These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bosentan improves exercise capacity in adolescents and adults after Fontan operation: the TEMPO (Treatment With Endothelin Receptor Antagonist in Fontan Patients, a Randomized, Placebo-Controlled, Double-Blind Study Measuring Peak Oxygen Consumption) study. Hebert A, Mikkelsen UR, Thilen U, Idorn L, Jensen AS, Nagy E, Hanseus K, Sørensen KE, Søndergaard L. Circulation; 2014 Dec 02; 130(23):2021-30. PubMed ID: 25446057 [Abstract] [Full Text] [Related]
5. Impact of bosentan on exercise capacity in adults after the Fontan procedure: a randomized controlled trial. Schuuring MJ, Vis JC, van Dijk AP, van Melle JP, Vliegen HW, Pieper PG, Sieswerda GT, de Bruin-Bon RH, Mulder BJ, Bouma BJ. Eur J Heart Fail; 2013 Jun 02; 15(6):690-8. PubMed ID: 23361871 [Abstract] [Full Text] [Related]
6. Fontan Circulation over Time. Wolff D, van Melle JP, Bartelds B, Ridderbos FS, Eshuis G, van Stratum EBHJ, Recinos SJ, Willemse BWM, Hillege H, Willems TP, Ebels T, Berger RMF. Am J Cardiol; 2017 Aug 01; 120(3):461-466. PubMed ID: 28624095 [Abstract] [Full Text] [Related]
15. ARIES-3: ambrisentan therapy in a diverse population of patients with pulmonary hypertension. Badesch DB, Feldman J, Keogh A, Mathier MA, Oudiz RJ, Shapiro S, Farber HW, McGoon M, Frost A, Allard M, Despain D, Dufton C, Rubin LJ, ARIES-3 Study Group. Cardiovasc Ther; 2012 Apr 15; 30(2):93-9. PubMed ID: 21884013 [Abstract] [Full Text] [Related]
16. Brief report: effect of ambrisentan treatment on exercise-induced pulmonary hypertension in systemic sclerosis: a prospective single-center, open-label pilot study. Saggar R, Khanna D, Shapiro S, Furst DE, Maranian P, Clements P, Abtin F, Dua S, Belperio J, Saggar R. Arthritis Rheum; 2012 Dec 15; 64(12):4072-7. PubMed ID: 22777623 [Abstract] [Full Text] [Related]
17. Oxygen pulse kinetics in Fontan patients during treadmill ramp protocol cardiopulmonary exercise testing. Bansal M, Fiutem JJ, Hill JA, O'Riordan MA, Zahka KG. Pediatr Cardiol; 2012 Dec 15; 33(8):1301-6. PubMed ID: 22466709 [Abstract] [Full Text] [Related]
19. Respiratory Training Late After Fontan Intervention: Impact on Cardiorespiratory Performance. Ait Ali L, Pingitore A, Piaggi P, Brucini F, Passera M, Marotta M, Cadoni A, Passino C, Catapano G, Festa P. Pediatr Cardiol; 2018 Apr 15; 39(4):695-704. PubMed ID: 29349618 [Abstract] [Full Text] [Related]
20. Impaired Pulmonary Function is an Additional Potential Mechanism for the Reduction of Functional Capacity in Clinically Stable Fontan Patients. Turquetto ALR, Canêo LF, Agostinho DR, Oliveira PA, Lopes MICS, Trevizan PF, Fernandes FLA, Binotto MA, Liberato G, Tavares GMP, Neirotti RA, Jatene MB. Pediatr Cardiol; 2017 Jun 15; 38(5):981-990. PubMed ID: 28500413 [Abstract] [Full Text] [Related] Page: [Next] [New Search]